June 13th, 2018
•Here, we present a protocol for the generation of induced pluripotent Stem Cells (iPSCs) from Li-Fraumeni Syndrome (LFS) patient derived fibroblasts, differentiation of iPSCs via mesenchymal stem cells (MSCs) to osteoblasts, and modeling in vivo tumorigenesis using LFS patient-derived osteoblasts.
Related Videos
Establishment of Cancer Stem Cell Cultures from Human Conventional Osteosarcoma Video (Video) | JoVE
A Preclinical Mouse Model of Osteosarcoma to Define the Extracellular Vesicle-mediated Communication Between Tumor and Mesenchymal Stem Cells Video (Video) | JoVE
Flow Cytometry to Estimate Leukemia Stem Cells in Primary Acute Myeloid Leukemia and in Patient-derived-xenografts, at Diagnosis and Follow Up Video (Video) | JoVE
Isolation and Characterization of Tumor-initiating Cells from Sarcoma Patient-derived Xenografts Video (Video) | JoVE
A Three-dimensional Thymic Culture System to Generate Murine Induced Pluripotent Stem Cell-derived Tumor Antigen-specific Thymic Emigrants Video (Video) | JoVE
Patient-derived Heterogeneous Xenograft Model of Pancreatic Cancer Using Zebrafish Larvae as Hosts for Comparative Drug Assessment Video (Video) | JoVE
A Melanoma Patient-Derived Xenograft Model Video (Video) | JoVE
Physiologic Patient Derived 3D Spheroids for Anti-neoplastic Drug Screening to Target Cancer Stem Cells Video (Video) | JoVE
Using Human Induced Pluripotent Stem Cells for the Generation of Tumor Antigen-specific T Cells Video (Video) | JoVE
Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts Video (Video) | JoVE
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved